Moreover, BRG1 expression was found increased in primary melanoma and metastatic melanoma when compared with dysplastic nevi and reduction of BRG1 expression by siRNA in melanoma cell lines resulted in a significantly decreased cell proliferative ability [28], concordant with our previous results [26] and findings presented here. The gene discussed is SMARCA4; the disease is metastatic melanoma.